LABA and LAMA are used to relieve the symptoms of bronchoconstriction, whereas ICS serve to reduce the airway inflammation. Currently, Spiriva (tiotropium bromide; Pfizer/Boehringer Ingelheim ...

The impact of the addition of tiotropium (Tio) to ICS + LABA therapy on all-cause mortality, hospital admissions for respiratory disease, and emergency oral corticosteroid bursts was evaluated.

LAMA are potent and first-line bronchodilators in COPD but generally take longer to have effect than their LABA bronchodilator counterparts. Tiotropium and aclidinium are currently available for ...